Status:
ACTIVE_NOT_RECRUITING
The Effects of Almond Consumption on Functional Performance and Activity in Overweight Active Older Adults
Lead Sponsor:
Florida State University
Collaborating Sponsors:
Almond Board of California
Conditions:
Overweight
Eligibility:
All Genders
50-59 years
Phase:
NA
Brief Summary
The overall objective of this proposed randomized, crossover study is to determine the effect of 12 weeks of almond consumption, ingested as a snack twice daily, on energy expenditure, performance and...
Detailed Description
By 2030 it estimated that 20% of individuals in the United States (U.S.) will be 65 years of age or older, indicating a shift in demographics over the past century. The aging process is strongly assoc...
Eligibility Criteria
Inclusion
- 50 physically active men and postmenopausal women (free of menstruation for 12 consecutive months)
- Between the ages of 50-59 years
- Free of any chronic diseases such as cancer
- Active lifestyle (\>30 minutes, 3 days/week)
- BMI of 25.0 kg/m2 to 29.9 kg/m2 will be included
- There will be no restrictions based on race, ethnicity, or socioeconomic status.
Exclusion
- Individuals diagnosed with cardiovascular diseases (CVD) Type 2-diabetes
- Uncontrolled hypertension (≥160/100 mmHg)
- BMI \<25.0 kg/m2 or \>29.9 kg/m2
- Other active chronic diseases such as cancer, asthma, glaucoma, kidney, liver and pancreatic disease
- Those who are not post-menopausal or on hormone replacement therapy
- Taking more than one anti-hypertensive or have been taking them for less than 3 months -Any musculoskeletal or orthopedic problem that would otherwise prevent completing the study Participants participating in a weight loss program or having lost or gain ≥10% bodyweight within the last 6 months
- Currently using tobacco
- Consumption of \>12 alcoholic drinks/week
- Nut allergies
- Frequent tree nut consumers (\>2 servings/week)
- In concurrent participation with another investigational study
- Currently consuming any performance supplement (i.e. creatine, nitric oxide, whey/casein protein, branched chain amino acids).
Key Trial Info
Start Date :
March 2 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04778371
Start Date
March 2 2021
End Date
May 1 2026
Last Update
December 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Florida State University
Tallahassee, Florida, United States, 32306